Article thumbnail
Location of Repository

A review of anabolic therapies for osteoporosis

By Nancy E Lane and Ariella Kelman


Osteoporosis results from a loss of bone mass and bone structure such that the bone becomes weak and fractures with very little trauma. Until recently, the approved osteoporosis therapies prevented more bone loss by altering osteoclast activity and lifespan. Recently, attention has turned away from osteoclast inhibition to agents that can stimulate the osteoblast to form new bone, or anabolic agents. This article reviews both approved and experimental anabolic agents that improve bone mass by improving osteoblast activity, or increasing osteoblast number. The use of the anabolic agents to improve bone mass and strength followed by agents that prevent the new bone mass from being lost may offer the ability to cure osteoporosis and reduce bone fracture healing time

Topics: Review
Publisher: BioMed Central
Year: 2003
OAI identifier:
Provided by: PubMed Central

Suggested articles

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.